| 13:00 ~ 13:15 |
Beyond the Crossroads: Expert Consensus on Optimal Sequencing after First-Line ARPI failure |
Silke GILLESSEN (Swiss) |
|
| 13:15 ~ 13:25 |
Refining the mCRPC Treatment Algorithm: The Strategic Integration of PSMA-RLT Pre- and Post-Taxane |
Amit BAHL (UK) |
|
| 13:25 ~ 13:35 |
Biomarker-driven therapy: PARP inhibitors, HRR alterations, MSI-H, and testing strategies |
Joseph KIM (USA) |
|
| 13:35 ~ 13:45 |
Supportive care as disease-modifying care: bone protection, pain, frailty, and QoL metrics |
Kinh Luan THAI (Vietnam) |
|
| 13:45 ~ 14:10 |
Case-based discussion |
Moderator: Bum Sik TAE (Korea) Discussant: Sangchul?LEE (Korea) Yu Seob SHIN (Korea) Silke GILLESSEN (Swiss) Amit BAHL (UK) Joseph KIM (USA) Kinh Luan THAI (Vietnam) |
|